Trials / Completed
CompletedNCT04528043
Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit
Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Impact on the Mortality and Morbidity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 179 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher risk of resistance.
Conditions
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2019-01-10
- Completion
- 2019-12-31
- First posted
- 2020-08-27
- Last updated
- 2020-08-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04528043. Inclusion in this directory is not an endorsement.